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Abstract
Background: The unique features of human embryonic stem (hES) cells make them the best
candidate resource for both cell replacement therapy and development research. However, the
molecular mechanisms responsible for the simultaneous maintenance of their self-renewal
properties and undifferentiated state remain unclear. Non-coding microRNAs (miRNA) which
regulate mRNA cleavage and inhibit encoded protein translation exhibit temporal or tissue-specific
expression patterns and they play an important role in development timing.
Results: In this study, we analyzed miRNA and gene expression profiles among samples from 3
hES cell lines (H9, I6 and BG01v), differentiated embryoid bodies (EB) derived from H9 cells at
different time points, and 5 adult cell types including Human Microvascular Endothelial Cells
(HMVEC), Human Umbilical Vein Endothelial Cells (HUVEC), Umbilical Artery Smooth Muscle
Cells (UASMC), Normal Human Astrocytes (NHA), and Lung Fibroblasts (LFB). This analysis
rendered 104 miRNAs and 776 genes differentially expressed among the three cell types. Selected
differentially expressed miRNAs and genes were further validated and confirmed by quantitative
real-time-PCR (qRT-PCR). Especially, members of the miR-302 cluster on chromosome 4 and miR-
520 cluster on chromosome 19 were highly expressed in undifferentiated hES cells. MiRNAs in
these two clusters displayed similar expression levels. The members of these two clusters share a
consensus 7-mer seed sequence and their targeted genes had overlapping functions. Among the
targeted genes, genes with chromatin structure modification function are enriched suggesting a role
in the maintenance of chromatin structure. We also found that the expression level of members of
the two clusters, miR-520b and miR-302c, were negatively correlated with their targeted genes
based on gene expression analysis
Conclusion:  We identified the expression patterns of miRNAs and gene transcripts in the
undifferentiation of human embryonic stem cells; among the miRNAs that are highly expressed in
undifferentiated embryonic stem cells, the miR-520 cluster may be closely involved in hES cell
function and its relevance to chromatin structure warrants further study.
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Background
Human embryonic stem (hES) cells possess unique fea-
tures: self-renewal and pluripotency. They can be contin-
uously cultured in undifferentiated status and give rise to
differentiated cells and tissues of all three germ layers.
With these unique properties, it is reasonable to postulate
that hES cells are the best resource not only for cell
replacement therapy but also for studying human devel-
opmental biology. However, little has been done to
understand the molecular mechanisms responsible for
the maintenance of the undifferentiated status and the dif-
ferentiation process of human embryonic stem cells.
MicroRNAs (miRNAs) are small (19 to 25 nts) endog-
enous non-coding RNA molecules that post-transcription-
ally regulate gene expression [1,2]. Some miRNAs interact
with their targets through imprecise base-pairing, result-
ing in the arrest of translation [3,4]; while others interact
with their mRNA targets through near-perfect comple-
mentary and direct targeted mRNA degradation [5,6].
Many miRNAs exhibit temporal or tissue-specific expres-
sion patterns [7,8], and are involved in a variety of devel-
opmental and physiological processes [9,10].
It has been reported that miRNAs play an important role
in mediating the regulation of development. For example,
Dcr-1, which is essential for miRNA biogenesis, is
required in germline stem cell (GSC) division in Dro-
sophila melanogaster [11]; miR-143 regulates the differ-
entiation of adipocytes [12]; miR-1 regulates cardiac
morphogenesis, electrical conduction, and the cardiac cell
cycle [13]; miR-181 is related to differentiation of B-line-
age cells [14], while miR-155 is associated with develop-
ment of immune system [15]. Signature miRNAs, such as
the miR-302 family, the miR-200 family have been
reported in human [16,17] and mouse embryonic stem
cells [18-20]. The unique patterns of miRNA expression in
embryonic stem cells suggest they are involved in main-
taining "stemness".
Identifying mRNAs that are directly targeted by a specific
miRNA is a major obstacle in understanding the miRNA
functions. Computational prediction of miRNA targeted
genes based on multiple parameters such as 5' seed
sequence matching, free energy score and conservation
among different species have been informative and
rewarding, but lack experimental confirmation. Simulta-
neous profiling of miRNA and mRNA expression from the
same sample can be a good strategy to identify functional
miRNA targets in addition to computational selection. For
miRNAs which lead to targeted mRNA degradation, their
expression profile should reveal an inverse relationship
with their cognate targets. A global analysis of both miR-
NAs and mRNAs expression across 16 human cell lines
identified inverse correlated pairs of miRNA and mRNA
[21]. Another analysis using 88 normal and cancerous tis-
sue samples found that miRNA-mRNAs paired expression
profiles could improve the accuracy of miRNA-target pre-
diction on a large-scale [22]. However, the relationship
between hES-specific miRNAs and their target genes is not
yet well documented. To our knowledge there is only one
article addressing this question, but it reported that nega-
tive correlations of miRNA and mRNA do not directly pre-
dict functional targeting in human embryonic stem cells
[17].
In the present study, we applied two custom microarray
platforms to detect global expression profiles of miRNAs
and transcripts using three hES cell lines, embryonic bod-
ies (EB) produced from one of the cell lines and five types
of terminally differentiated adult cells. The integration of
miRNA expression levels with gene expression levels pro-
vided evidence to support the negative correlation
between hES-specific miRNAs and their target mRNAs
expression level as a whole in human embryonic stem
cells. These results will help to unravel the biological sig-
nalling pathways of hES cells.
Results
MiRNA expression profiling
The expression of hES-specific markers was assessed by
immunofluorescence and flow cytometry. Our results
revealed that over 90% of the hES cells were positive for
Oct4, Nanog, Sox2, Tra-1-81, and Ssea4, but negative for
Ssea1, suggesting that most of the hES cells were in an
undifferentiation state.
Global miRNA expression was analyzed among the 10
samples from 3 undifferentiated hES cell lines, 6 samples
from EB and 5 samples from adult cell via a microarray
platform (Gene Expression Omnibus accession number
GSE12229). Unsupervised hierarchical clustering analysis
separated the samples to three major groups: the hES cells,
embryoid body (EB), and adult cells (Figure 1). Without
statistic stratification, signature miRNAs specific for hES
were distinguishable from EB and adults cell suggesting a
diverse biological entity and fundamental difference in
miRNA expression patterns.
We identified 104 miRNA differentially expressed by the
hES, EB and adult cell types (F-test, P < 0.01, FDR < 0.05).
These included 38 miRNA upregulated in hES cells, 31
upregulated in EB cells, and 35 upregulated in adult cells
(Figure 2). The 20 miRNAs most highly expressed in hES
cells, EB, and adult cells respectively were shown in addi-
tional file 1. MiR-302a, miR-302b, miR-302c, miR-302d,
miR-367, and miR-200c were increased in hES and have
previously been reported to be hES-specific [16,17]. More-
over, the upregulation of these miRNAs in hES was con-Journal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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Unsupervised hierarchical clustering of miRNAs Figure 1
Unsupervised hierarchical clustering of miRNAs. The expression levels of miRNAs were presented as normalized cy5/
cy3 ratios, upregulated miRNAs were shown as red and downregulated miRNAs were shown as green. I6, H9 and BG01v are 
names of human embryonic stem (hES) cells lines. P denoted the number of passages of the cell lines. H9-EB denoted embryoid 
body (EB) prepared from cell line H9 and the day indicates the time in culture. HMVEC = human microvascular endothelial 
cells, HUVEC = human umbilical vein endothelial cells, UASMC = umbilical artery smooth muscle cells; NHA = normal astro-
cyte and LFB = lung fibroblasts. Unsupervised hierarchical clustering analysis separated the samples to three major groups: hES 
cells, embryoid body (EB), and adult cells.
unsupervised clustering
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supervised hierarchical clustering of miRNAs Figure 2
supervised hierarchical clustering of miRNAs. Supervised clustering using the 104 differentially expressed miRNAs clas-
sified the samples into three groups as well: hES, EB, and adult cells. Node I contained the miRNAs that were upregulated in 
hES cells, node II contained the miRNAs upregulated in adult cells, node III contained the miRNAs upregulated in EB. HMVEC 
= human microvascular endothelial cells, HUVEC = human umbilical vein endothelial cells, UASMC = umbilical artery smooth 
muscle cells; NHA = normal astrocyte and LFB = lung fibroblasts.
supervised clustering
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firmed by qRT-PCR with high correlation (R2 = 0.65–0.9,
data not shown).
Most miRNAs that are organized in clusters in close prox-
imity on a chromosome have similar expression levels,
indicating the possibility of transcribed in polycistronic
fashion under the same promoter [16,23]. From our data,
the expression of miR-302a, miR-302b, miR-302c, miR-
302d and miR-367, which are co-located in a cluster on
chromosome 4 were highly correlated (R2 = 0.78–0.98).
Likewise, miR-200c and miR-141 located in a cluster on
chromosome 12 were also highly correlated (R2 = 0.94).
Our results also confirmed other miRNAs that are upregu-
lated in hES cells such as miR-299-3p, miR-369-3p, miR-
96 and miR-372[16,17,24,25]. However, miR-371, which
is located in the same cluster with miR-372, was not dis-
covered to be upregulated in hES cells by our results.
Another member in this cluster, miR-373, was found to be
upregulated in EB by our results, which was consistent
with a recent report [26]. The differences among these
studies may be attributed to the different cell lines tested
or the different technical platforms used in assessing
miRNA expression.
Most interestingly, 21 miRNAs located in a cluster on
chromosome 19 exhibit similar expression levels. A por-
tion of this large cluster has previously been found to be
primate-specific and placenta-associated [27,28]. Among
these miRNAs, miR-518b, miR-518c, miR-519b, miR-
519c, miR-520a, miR-520c, miR-520e, miR-520g, and
miR-524* are over-expressed in undifferentiated hES cells
[24,26,29]. Besides these 9 miRNAs, we also identified 12
more miRNAs in this cluster; they were miR-515-5p, miR-
517a, miR-517b, miR-517c, miR-519e, miR-520b, miR-
520d, miR-520f, miR-520h, miR-521, miR-525-3p, and
miR-526b*. The similar expression levels of these miR-
NAs imply that they may share functional similarity.
We identified three miRNA clusters that were upregulated
in embryoid body (EB). One was the Oncomir cluster
consisting of miR-17-5p, miR-20a, miR-18a, miR-19a,
miR-19b, and miR-92a located on chromosome 13. The
second was located on chromosome 7 and includes miR-
25, miR-93 and miR-106b. The third was located on chro-
mosome X and includes miR-106a, miR-363, and miR-
20b. We also identified EB upregulated miRNAs that have
not been previously reported such as miR-130a, miR-
301a, and miR-135, miR-190, miR-30c, and miR-30e.
A maternally-expressed imprinted miRNA cluster on chro-
mosome 14 [30] was upregulated in adult cells. This clus-
ter included miR-495, miR-376a, and miR-369-5p. In
addition, we identified 8 miRNAs of the let-7 family that
upregulated in adult cells, whose expression was detected
in hES cells [16,26], and was upregulated at the end of
embryonic development [31].
Gene expression profiling
We assessed global hES gene expression profiles on 3 sep-
arate passages of cells from 3 different hES cell lines, EB
samples at 3 different time points, and 5 types of adult
cells, HUVEC, HMVEC, UASMC NHA, and LFB using a
custom spotted oligonucleotide microarray (Gene Expres-
sion Omnibus accession number GSE12228). Unsuper-
vised hierarchical clustering using filtered genes classified
the samples into three groups: the hES group, EB group
and adult cell group. This clustering analysis also identi-
fied one node containing the hES cell markers POU5F1
(OCT4), LEFTY1, TDGF1 and DPPA4 (Figure 3).
We identified 776 genes differentially expressed among
hES, EB and adult cell types (F-test, cut-off p < 0.005, FDR
< 0.05). Hierarchical clustering analysis of these genes
also divided the samples into three groups, hES, EB, and
adult cells, and divided the genes into 4 major nodes (Fig-
ure 4). The node containing 226 genes that were upregu-
lated in hES cells (node B) included the previously
identified hES markers OCT4, TDGF1, LEFTY1, DNMT3B,
GAL, DPPA4, UGP2, TERF1, GABRB3, CD24, FAM46B,
SALL4, TCEA1, ZNF398, NODAL, and ACVR2B [32-35].
The node containing genes upregulated in EB (node C)
included the genes HAND1, HOXA1, HOXB2, MSX1,
MSX2, MEIS1, FGF9 and FREM1 which are involved in
morphogenesis and development [36-39]. This node also
included transcription factors GATA5, ELF3, MSRB2,
MIER1, XRCC6 and ZFHX3 which are related to develop-
ment. A node containing a small number of genes that
were upregulated both in EB and in hES cells (node A)
included GLI1, ISL1, CRABP1, and KRT9. Of note is that
GLI1 activation is required in sonic hedgehog (Shh) sig-
nalling pathway [40], which is essential in regulating
development, stimulation of the Shh pathway also results
in the upregulation of GLI1 in hES cells [41], suggesting
that Gli1 plays an important role in embryological devel-
opment and hES cell differentiation.
Correlation of miRNAs and their predicted targets
The mRNAs that are predicted to be targets of specific
miRNAs are expressed at significantly lower levels [42,43].
This is likely caused by miRNA-mediated destabilization
of target mRNA. To determine whether the negative corre-
lation between miRNA and gene expression levels actually
reflected miRNA-target relationships in hES cells, we cal-
culated the correlation coefficients between the expres-
sion levels of hES upregulated miRNAs and the levels of
their predicted targets. The predicted targets for each
miRNA were downloaded from miRNAMap2.0 [44] and
their expression value were extracted from our gene
expression microarray data. To avoid random correlation,Journal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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unsupervised hierarchical clustering of genes Figure 3
unsupervised hierarchical clustering of genes. The gene expression data is presented as normalized Log cy5/cy3 ratios, 
upregulated genes are shown as red, downregulated genes are shown as green. I6, H9 and BG01v are names of hES cells lines. 
P denotes the number of passages of the cell lines. H9-EB denotes embryoid body (EB) prepared from cell line H9 and the day 
indicates the time in culture. HMVEC = human microvascular endothelial cells, HUVEC = human umbilical vein endothelial 
cells, UASMC = umbilical artery smooth muscle cells; NHA = normal astrocyte and LFB = lung fibroblasts. Unsupervised hier-
archical clustering analysis separated the samples to three major groups: hES cells, embryoid body (EB), and adult cells; the 
node containing hES markers was highlighted by white lines.
hES upregulated
genes
 unsupervised clustering 
hESC cells adult cellsJournal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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supervised hierarchical clustering of genes Figure 4
supervised hierarchical clustering of genes. Supervised clustering using the differentially expressed gene classified the 
samples into three groups: hES cells, EB, and adult cells. Node A contained the genes that were upregulated in both hES cells 
and EB, node B contained the genes upregulated in hES cells only, node C contained the genes upregulated in EB only, and node 
D contained the genes that were upregulated in adult cells. HMVEC = human microvascular endothelial cells, HUVEC = human 
umbilical vein endothelial cells, UASMC = umbilical artery smooth muscle cells; NHA = normal astrocyte and LFB = lung 
fibroblasts.
(B) hES cells upregulated genes
(C) EB upregulated genes
(A) Adult cells and EB shared genes
(D) Adult cells upregulated genes
A
B
C
D
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hESC cells EB adult cellsJournal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
Page 8 of 17
(page number not for citation purposes)
we calculated the correlation coefficients between miRNA
expression levels and randomly-selected non-target genes
of the same number. In general, the expression levels of
miRNAs were both positively and negatively correlated
with their predicted targets for all the miRNAs analyzed.
However, we still observed a preponderance of negative
correlation over positive correlation between some spe-
cific miRNAs and their targets. The distribution of the cor-
relation coefficients for miR-302c-target genes was shifted
toward the negative side compared to that of the miR-
302c-non-target genes. This was also true for the miR-
520b-target genes. The mean of the correlation coeffi-
cients between the two sets, targeted and non-targeted
genes, was significantly different (p = 0.0003 for miR-302c
and p = 0.049 for miR-520b) (Figure 5).
Validation of microarray results
Using qRT-PCR we found that the expression levels of
miR-302b, miR-302c, miR-367, miR-200c, miR-519b,
and miR-520b were much higher in hES cells than in
either EB or adult cells (Figure 6, panel A). The difference
in the expression of miR-200c, miR-302b, and miR-367
between hES cells and EB, and between hES cells and
adult cells was significant (P < 0.05). The difference in
miR-302c expression between hES cells and adult cells
was also significant (P < 0.05). In particular, the expres-
sion of miR-519b was 8-fold greater in hES cells than in
EB cells and it was not even detected in adult cells. The
expression of miR-520b was 26-fold greater in hES cells
then in EB cells (P < 0.05) and it was detected only in two
types of adult cells HMVEC and HUVEC.
Differences in the expression of EB signature miRNA were
also confirmed by qRT-PCR. The expression of miR-106a,
Correlation coefficients of miRNA-target gene pairs Figure 5
Correlation coefficients of miRNA-target gene pairs. The expression of miR-302c and miR-502b and their predicted 
target genes was analyzed by correlation analysis. The distribution of the correlation coefficients for miR-302c-target gene 
pairs (red line) was shifted toward negative side compared to that of the miR-302c-non-target gene pairs (blue line). The mean 
of correlation coefficients between the two sets was significantly different (p = 0.0003). The distribution of correlation coeffi-
cients for miR-520b-target gene pairs (red line) was also shifted toward negative side compared to the miR-520b-non-target 
gene pairs (blue line) and the mean of correlation coefficients was significant (p = 0.049).
miRNA-targets
miRNA-non-targetsJournal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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miR-106b, miR-17-5p, miR-92, miR-93, miR-130a, miR-
20a and miR-190 were much higher in EB than in either
hES cells or adult cells (Figure 6, panel B). For miR-106b,
miR-92, miR-93, miR-130a and miR-190, the difference
in their expression between EB and hES cells and between
EB and adult cells were significant (P < 0.05). The differ-
ence in expression of miR-17-5p between EB and hES
cells, and of miR-20a between EB and adult cells were also
significant (P < 0.05).
We also confirmed that let-7b, let-7i, miR-221, miR-222
and miR-181a were much more highly expressed in adult
cells (Figure 6, panel C). The differences in expression of
these miRNA expression between adult cells and hES cells
and between adult cells and EB were significant (P < 0.05).
Of note, the expression levels of let-7b and let-7i were
much higher in hES cells than in EB, and this result was
consistent with both our microarray results and a previous
report [26], indicating that the let-7 family plays impor-
tant role in the maintaining hES cells function although
their expression level was much lower than in adult cells.
We also confirmed that miR-222 was more highly
expressed in adult cells, although it was reported to be
enriched in hES cells [17]. Actually, miR-222 was also
expressed in multiple adult cell lines [16], forebrain and
midbrain [45], and hippocampus [46]; it was upregulated
Measurement of differentially expressed miRNAs by qRT-PCR Figure 6
Measurement of differentially expressed miRNAs by qRT-PCR. The differentially expressed miRNAs were analyzed 
by qRT-PCR using the relative quantification method. The results were normalized with endogenous control RNU48 and the 
fold change was calculated by equation2-ΔΔCt. The y-axis indicates the Log2-transformed fold change relative to the calibrator. 
Expression of levels of miR-200c, miR-302b, miR-302c, miR-367, miR-519b, and miR-520b were the greatest in hES cells (panel 
A). The expression of miR-106a, miR-106b, miR-17-5p, miR-92, miR-93, miR-190, miR-20a and miR-130 were highest in EB 
(panel B). Tumor suppressor let-7b/7i, miR-221, miR-222 and miR-181a were expressed at the highest levels in adult cells 
(panel C). Statistical significance was determined by student t-test. Red triangles indicate a significant difference (P < 0.05) ver-
sus EB, green circles indicate a significant difference (P < 0.05) versus adult cells, and blue diamonds indicate a significant differ-
ence (P < 0.05) versus hES cells.
•• • • 
•• ••


• ♦• ♦
•• ♦ ♦• • ♦
•• •• ♦
 ♦  ♦ 
 ♦ ♦ 
♦
 P<0.05 when compared to EB;    • P<0.05 when compared to adult cells;   ♦P<0.05 when compared to adult cells
(a) hES cells upregulated miRNAs (b) EB upregulated miRNAs (c) adult cells upregulated miRNAsJournal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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in the differentiation process of undifferentiated hES cells
to neural progenitor cells and then declined upon further
differentiation [25]; it was also downregulated in erythro-
poietic culture of cord blood CD34+ progenitor cells [47].
Selected differentially expressed genes identified by
microarray analysis were also validated via qRT-PCR.
Markers for hES cells, POU5F1 (OCT4), LEFTY1 and
TDGF1 were highly expressed in hES cells (Figure 7). The
expression of OCT4 by hES cells was upregulated by 12-
fold, LEFTY1 by 70-fold and TDGF1 by 19-fold compared
to EB. Compared to adult cells, expression of OCT4 in hES
was increased by 4,324-fold, LEFTY1  by 769-fold, and
TDGF1 by 2,443-fold. We did not find that Nanog was
upregulated in hES cells by microarray analysis, and by
qRT-PCR its expression was increased by only 3-fold in
hES cells compared to EB cells and 25-fold to adult cells.
This discrepancy may have resulted from the fact that
microarray platform is less sensitive than qRT-PCR. Anal-
ysis by qRT-PCR confirmed that both HAND1 and GATA5
were upregulated in EB, but were not detected in adult
cells; HAND1 was only expressed in 1 hES sample, GATA5
expression was increased by 37-fold in EB cells compared
to hES cells. The expression level of NFIB  was much
higher in adult cells than in either hES cells or EB (Figure
7) which was also consistent with the microarray results.
Functional comparison of miR-302 cluster and miR-520 
cluster
Among the miRNAs upregulated in hES cells, we observed
7 miRNAs were located in the miR-302 cluster and 21
miRNAs were located in miR-520 cluster. Most of these
miRNAs had highly similar sequences at the 5' end seed
region. In particular, miR-302a, miR-302b, miR-302c,
miR-302d, miR-519b, miR-519c, miR-520a, miR-520b,
miR-520c, miR-520d, and miR-520e had a consensus seed
sequence: AAGUGC (Figure 8, panel A). To infer the func-
tion of these miRNAs, we predicted 2,436 targets for the
miR-302 cluster and 4,691 targets for the miR-520 cluster
by querying the public database miRNAMap 2.0 http://
mirnamap.mbc.nctu.edu.tw, and 2,284 target genes were
shared by both clusters suggesting functional similarity.
Gene Ontology (GO) enrichment analysis confirmed that
the inferred functions of miRNAs within the miR-302 and
miR-520 clusters were overlapping based on their involve-
ment in cell growth, negative regulation of cellular meta-
bolic process, negative regulation of transcription, and
small GTPase mediated signal transduction. To visualize
the functions of these miRNA targeted genes, a binary (red
indicate participate in the functional category and green
indicate not) heatmap was used to indicate functional
commonality among all miRNAs in miR-302 and miR-
520 clusters. MiR-520b, miR-302b, miR-302c, miR-302d,
miR-519c, miR-520a and miR-302a were clustered closely
base on the 48 GO terms analyzed. Interestingly, out of 48
functional categories analyzed, 6 related to chromatin
structure were identified in this cluster, which included
histone modification, covalent chromatin modification,
establishment and or maintenance of chromatin architec-
ture, chromosome organization and biogenesis, and chro-
matin modification (Figure 8, panel B).
Discussion
The present study investigated hES cell specific miRNAs
profiles and transcription profiles through the compari-
son of partially differentiated EB and terminal differenti-
ated adult cells. From miRNA array analysis, we identified
a total of 104 differently expressed miRNAs that clearly
segregate the three cell types analyzed. miRNAs expressed
at high levels in hES cells and downregulated during dif-
ferentiation or in adult cells included the well-known
miR-302 family, miR-200 family, and miR-372. In addi-
tion, we identified 21 hES upregulated miRNAs that were
co-localized in a cluster on chromosome 19, the miR-520
cluster, many of which shared consensus seed sequence
with miR-302 family and which can be used as candidate
biomarkers for pluripotency (Additional file 1).
In the present study, miR-200b, miR-200c and miR-141,
all members of the miR-200 family, were upregulated in
hES cells. The function of miR-200 family in hES is not
well documented. It has been reported that miR-200 fam-
ily targets E-cadherin transcriptional repressors ZEB1 and
ZEB2, thus inhibiting epithelial to mesenchymal transi-
tion (EMT) [48-50], which facilitates tissue remodelling
during embryonic development. The miR-200 family is
also required for the proper differentiation of olfactory
progenitor cells in zebrafish model [51], indicating that
the miR-200 family is involved in development. It has
been shown that the inhibition of miR-141 decreases
growth of cholangiocarcinoma cells [52]. Moreover, miR-
200 family have been reported to be upregulated in many
malignant tumors such as hepatocellular carcinoma [53],
malignant cholangiocytes [52], and ovarian cancer [54].
Thus our results are consistent with the previous report
that oncogenic miRNAs were upregulated in hES cells[24],
suggesting a possible function of blockade of cell differen-
tiation.
Our results confirmed the recent report that majority of
miRNA genes in hES cells were expressed from Chromo-
somes 19 and X [55] and demonstrated the significant
upregulation of miR-520 cluster in hES cells. Less is
known about the function of the miR-520 cluster. miR-
520h has been reported to be highly expressed in hemat-
opoietic stem cells (HSCs) from human umbilical cord
blood, and it promotes differentiation of HSCs into pro-
genitor cells by inhibiting ABCG2 expression[56].Journal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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Measurement of differentially expressed genes byqRT-PCR Figure 7
Measurement of differentially expressed genes byqRT-PCR. Quantitative real-time PCR confirmed the expression of 3 
genes found by microarray analysis to be upregulated in hES: POU5F1 (OCT4), LEFTY1, and TDGF1, and 2 genes upregulated in 
EB: HAND1 and GATA5, and 1 gene upregulated in adult cells: NFIB. In addition, the levels of another hES cell marker Nanog was 
also measured. The results were normalized by endogenous control 18s rRNA and the fold change was calculated by 
equation2-ΔΔCt. The y-axis indicates the Log2-transformed fold change relative to the calibrator.Journal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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Along with the reports of miR-302 family on chromo-
some 4 [16,17,19,25,26], several groups have reported the
expression of members of miR-520 cluster on chromo-
some 19 in hES cells [24,26,29]. Nine of these miRNAs
were consistent with our results. In addition, we identified
12 other hES upregulated miRNAs in this cluster: miR-
302a, miR-302b, miR-302c, miR-302d, miR-519b, miR-
519c, miR-520a, miR-520b, miR-520c, miR-520d, miR-
520e which share a consensus seed sequence: AAGUGC
[24]. The miR-302 cluster and miR-520 cluster target large
groups of genes which share overlapping functions based
on Gene Ontology (GO) analysis. The functions shared by
these two clusters included cell growth arrest, negative reg-
ulation of cellular metabolic process, negative regulation
of transcription, and small GTPase mediated signal trans-
duction. These gene functions correlate with hES cells
characteristics and biology suggesting a well controlled
and maintained stability. Of special note is that predicted
target genes for both clusters were associated with modifi-
cation of chromatin structure, which plays essential roles
in transcription regulation, DNA replication, DNA dam-
age repair and cell cycle control. Embryonic stem cells
have a unique bivalent chromatin structure which silences
developmental genes in ES cells while keeping them
poised for activation, thus providing a mechanism for
maintaining pluripotency [57]. The upregulation of miR-
302 cluster and miR-520 cluster in hES cells suggests their
ability to modulate local chromatin states which is neces-
sary for stem cell pluripotency [58,59].
Many of these miRNAs that were highly expressed in EB
belong to the miR-17-92 cluster located on chromosome
13. The expression of miR-92 has been reported in human
embryonic stem (ES) cells [16,26], mouse ES cells[20] or
Sequence and GO analysis of the miR-302 cluster and miR-520 cluster Figure 8
Sequence and GO analysis of the miR-302 cluster and miR-520 cluster. The members of the miR-302 and miR-520 
clusters had similar sequences; they shared a consensus seed sequence: AAGUGC (panel A, seed sequence is highlighted by 
the purple rectangle). At the Gene Ontology level, miR-520b, miR-302b, miR-302c, miR-302d, miR-519c, miR-520a, and miR-
302a formed a cluster (significant GO terms shown as red), and they shared GO terms related to chromatin structure modifi-
cations (Panel B).
(A)
(B)Journal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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human EB [17] depending on the reference sample used
for comparison. It should not be forgotten that hES cells
contain spontaneously differentiated cells, so it is difficult
to precisely determine which type of cells express miR-92.
The members of miR-17-92 cluster and its paralogs such
as miR-106a, miR-106b, miR-93, and miR-17-5p are
related to DNA replication and cell mitosis in cancer cells
[60-62], moreover, miR-17-5p and miR-20a can induce
heterochromatic features in promoters that undergo over-
lapping transcription and possess sequence complemen-
tarity to the miRNA seed region [63]. The most important
role of miR-17-92 cluster has been documented in associ-
ation with oncogenic process, lymphoproliferative disor-
ders, autoimmune disease and development [64-66].
Loss-of-function of the miR-17-92 cluster resulted in
smaller embryos and immediate postnatal death of ani-
mals [67], which could due to the deficiency of their roles
in the development of the heart, lung, and immune sys-
tem [66]. Additionally, we discovered that miR-30c and
miR-30e were upregulated in EB, which are expressed in
human leukaemia cells [68], indicating that they have a
role in controlling cell cycle and cell proliferation. This is
in line with an analysis which revealed that EB-enriched
miRNA targeted genes are involved in cell proliferation
and is in contrast with the function of hES-enriched miR-
NAs targeted genes [26].
The miRNAs that were upregulated in adult cells included
several members of the tumor suppressor let-7 family,
which inhibits cell growth and tumor cells motility [31].
They are expressed in the brain [17,46], osteocytes [69],
benign breast epithelial cells [61] and are downregulated
upon malignant transformation [60,61,70]. Let-7 miR-
NAs also regulate late embryonic development by sup-
pressing the expression of c-myc, RAS and high mobility
group A2 (HMGA2) [19,71]. Recently, it was reported that
the downregulation of let-7 is essential for self-renewal
and maintenance of the undifferentiated state of cancer
stem cells [72], indicating that this family of miRNAs has
a greater role in stem cell function than previously
described.
The currently available miRNA target prediction algo-
rithms always result in high false-positive rates. Several
reports have assumed that a negative correlation between
miRNA and gene expression levels is an indicator for a
miRNA-target gene relationship [21,43], if the function of
the miRNA is dominant in leading the mRNA target deg-
radation, however, most animal miRNAs pair to the 3'
UTRs of their targets by incomplete base-pairing through
their seed region [42]. We used the genome-wide miRNA
and mRNA expression data for the global correlation anal-
ysis between miRNAs and their predicted target genes. As
expected, both positive and negative correlations between
hES-specific miRNAs and their targets were observed. The
positive correlation indicates that the miRNAs were co-
expressed with their targets, and it is tempting to speculate
that miRNAs might function by suppressing the encoded
protein translation of their targets rather than by leading
mRNA cleavage. This positive correlation could also be
due to other miRNA regulatory function. For instance,
miR-373 induces the expression of E-cadherin and CSDC2
by targeting their promoter region and initiate their
expression[73]. Another mechanism is that the engage-
ment of miRNA and their targets at 3'UTR can sometimes
stabilize the mRNA and prolong the encoded protein
translation as exemplified by miR-155 which increases the
translation of TNF-α [74].
As more experimental data has been accumulated, the ver-
satile and complicated regulatory function of miRNA to
their targets has become more apparent. To understand
the predominant function of differentially expressed
miRNA in the current study, we focused on miR-302c and
miR-520b which were upregulated exclusively in hES and
their correlation with computational predicted targeted
genes. Although both upregulation and downregulation
was observed among the targets, a greater portion of
inverse correlation coefficients were detected between
miRNA and their targets than non-target pairs suggesting
a non-random correlation and possible miRNA induced
mRNA cleavage function. This analysis can provide useful
information concerning miRNA and their function in hES
cell biology. For example, the expression of nuclear factor
I/B (NFIB), one of miR-302c targeted genes, was repressed
in hES cells and upregulated in EB and adult cells. NFIB is
a transcription factor involved in brain development [75-
78], chondrocytic differentiation [79] and lung develop-
ment [78]. It is reasonable to assume that NFIB downreg-
ulation in hES may be involved in regulating hES
pluripotency and undifferentiated status. Experiments are
underway to test the function of miR-302c-target pairs.
Conclusion
In the present study, we analyzed miRNA profiles and
transcription profiles simultaneously on undifferentiated
hES cell, partially differentiated EB cell and terminal dif-
ferentiated cells and identified signature miRNA along
with a specific gene signature for hES cells. The differen-
tially expressed hES miRNAs were organized in clusters
and their expression was negatively correlated with their
predicted targets. Among the hES signature miRNAs, the
miR-520 cluster shared a similar expression pattern and
seed sequence as the well known miR-302 family and tar-
geted the same genes as the miR-302 family. In addition
to the inferred function of these miRNA in controlling cell
growth, negative regulation of cellular metabolic process,
negative regulation of transcription, and small GTPase
mediated signal transduction; these two clusters have aJournal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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similar inferred function in modification of chromatin
structure.
Methods
Cell culture and embryoid body differentiation
Human embryonic stem cell lines WA09 (H9), TE06 (I6),
and BG01v from WiCell Research Institute (Madison,
WI), Technion-Israel Institute of Technology (Haifa,
Israel) and ATCC (Manassas, VA) were cultured on mitot-
ically inactivated mouse embryonic fibroblast (MEF)
feeders using DMEM/F12 medium optimized for human
ESC culture (GlobalStem Inc, Rockville, MD) supple-
mented with 20% knockout serum replacement and 4 ng/
ml bFGF (both from Invitrogen, Gaithersburg, MD). Cul-
ture medium was changed daily and subculturing was per-
formed every 4–6 days by collagenase IV (1 mg/ml)
(Invitrogen, Gaithersburg, MD) digestion and mechanical
disruption. The undifferentiation state of hES cells was
determined by immunofluorescence detection of Pou5f1
(Oct4), Ssea4 (Millipore, Billerica, MA), Nanog (BD Bio-
science, San Jose, CA), Sox2 (R&D Systems Inc. Minneap-
olis, MN), Tra-1-81 (Abcam, Cambridge, MA) and
negative marker Ssea1 (Abcam, Cambridge, MA). The per-
centage of hES cells positive for Pou5f1 (Oct4), Sox2 and
Ssea4 was measured by flow cytometry (FCM).
For embryoid body (EB) differentiation, hES cells were
detached with collagenase IV and the cell aggregates were
briefly triturated then cultured in ultra low attachment
plates (Corning Inc, Corning, NY) for up to 14 days in
maintenance medium. The medium was changed every
three days.
The tested adult cells were Human Microvascular
Endothelial Cells (HMVEC), Human Umbilical Vein
Endothelial Cells (HUVEC), Umbilical Artery Smooth
Muscle Cells (UASMC), Normal human astrocytes (NHA)
(all from Lonza Inc, Walkersville, MD), and Lung Fibrob-
lasts (LFB) (ATCC). All of the adult cells were cultured
according to manufacturer's protocol.
MiRNAs expression profiling
A miRNA probe set was designed using mature antisense
miRNA sequences (Sanger data base, version 9.1) consist-
ing of 827 unique miRNAs from human, mouse, rat and
virus plus two control probes. The probes were 5' amine
modified and printed in duplicate on CodeLink activated
slides (General Electric, GE Health, NJ, USA) via covalent
bonding at the Infectious Disease and Immunogenetics
Section of the Department of Transfusion Medicine
(DTM) (Clinical Center, NIH, Bethesda, MD). 4 μg total
RNA isolated by using Trizol reagent (Invitrogen, Gaith-
ersburg, MD) was directly labelled with miRCURY™ LNA
Array Power Labelling Kit (Exiqon, Woburn, MA) accord-
ing to manufacture's procedure. The total RNA from
Epstein-Barr virus (EBV)-transformed lymphoblastoid cell
line was used as the reference for the miRNA expression
array assay. The test sample was labelled with Hy5 and the
reference with Hy3. After labelling, the sample and the ref-
erence were co-hybridized to the miRNA array at room
temperature overnight in the present of blocking reagents
as previously described[80] and the slides were washed
and scanned by GenePix scanner Pro 4.0 (Axon, Sunny-
vale, CA, USA).
Gene expression profiling
Total RNA was extracted using Trizol reagent and the RNA
quality was tested with the Agilent Bioanalyzer 2000 (Agi-
lent Technologies, Santa Clara, CA). The RNA was ampli-
fied into antisense RNA (aRNA) as previously
described[80]. Total RNA from PBMCs pooled from six
normal donors was extracted and amplified into aRNA to
serve as the reference. Both reference and test aRNA were
directly labelled using ULS aRNA Fluorescent Labelling kit
(Kreatech, Salt Lake City, UT) with Cy3 for reference and
Cy5 for test samples. Whole-genome human 36K oligo
arrays were printed in the Infectious Disease and Immu-
nogenetics Section of Transfusion Medicine, Clinical
Center, NIH (Bethesda, MD) using a commercial probe
set which contains 35,035 oligonucleotide probes, repre-
senting approximately 25,100 unique genes and 39,600
transcripts excluding control oligonucleotides (Operon
Human Genome Array-Ready Oligo Set version 4.0,
Huntsville, AL). The design is based on the Ensemble
Human Database build (NCBI-35c), with a full coverage
on NCBI human Refseq dataset (04/04/2005). Hybridiza-
tion was carried out at 42°C for 18 to 24 hours and the
arrays were then washed and scanned on a GenePix scan-
ner Pro 4.0 at variable photomultiplier tube to obtain
optimized signal intensities with minimum (< 1% spots)
intensity saturation.
Microarray data analysis
The resulting gene expression data files were uploaded to
the mAdb database and further analyzed using BRBArray-
Tools developed by the Biometric Research Branch,
National Cancer Institute http://linus.nci.nih.gov/BRB-
ArrayTools.html. Briefly, the raw data set was filtered
according to standard procedure to exclude spots with
minimum intensity and size. Then, the filtered data were
normalized using Lowess Smoother. For miRNA array, the
signal intensities were extracted via the R programming
language (version 2.6.0, http://cran.r-project.org/) and
the libraries provided by the Bioconductor project[81].
The background-subtracted data were then subject to var-
iance stabilization normalization[82] and imported into
BRBArray Tools http://linus.nci.nih.gov/BRB-Array
Tools.html. Differentially expressed miRNAs or genes
were identified using F-tests with a P-value cutoff of 0.01
(miRNA) or 0.005 (gene); P-values were adjusted for mul-Journal of Translational Medicine 2009, 7:20 http://www.translational-medicine.com/content/7/1/20
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tiple comparisons by False Discovery Rate < 0.05. Cluster-
ing and visualization of expression profiles was
preformed with Cluster and Treeview software http://
rana.lbl.gov/EisenSoftware.htm[83]. The correlation
between miRNA and target genes was performed using
CCA package http://cran.r-project.org/web/packages/
CCA/index.html[63]; for comparison, the expression level
of non-target genes of the same number was also corre-
lated with the miRNA expression. Density plot of correla-
tion coefficient distribution was generated in R
environment.
Validation of differentially expressed genes and miRNAs by 
qRT-PCR
For validation of microarray data, differentially expressed
genes were detected by using the pre-designed TaqMan®
Gene Expression Assays (Applied Biosystems, Foster City,
CA). Differentially expressed miRNAs were measured by
TaqMan microRNA Assays as previously reported [84].
The differences of expression were determined by relative
quantification method; the Ct values of the test genes or
miRNAs were normalized to the Ct values of endogenous
control (RNU48 for miRNA and 18s rRNA for mRNA).
The fold change was calculated using the equation 2-ΔΔCt.
Gene target prediction for miRNAs and Gene Ontology 
(GO) analysis
Gene target prediction was performed by querying the
miRNA Database miRANDA [85] and RNAhybrid [86]
through a miRNA gateway miRNAMap 2.0 http://mir
namap.mbc.nctu.edu.tw[44]. Gene annotations were
conducted using web-based tools Database for Annota-
tion, Visualization and Integrated Discovery (DAVID,
http://david.abcc.ncifcrf.gov/) [87] or High-throughput
GOminer http://discover.nci.nih.gov/gominer/
htgm.jsp[88]. The significantly (P < 0.05) enriched genes
involved in biological process for miRNA targets were
extracted; and heatmap was created using R 2.6.0.
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